Paxillin is a focal adhesion-associated, phosphotyrosinecontaining protein that may play a role in several signaling pathways. Paxillin contains a number of motifs that mediate protein ± protein interactions, including LD motifs, LIM domains, an SH3 domain-binding site and SH2 domain-binding sites. These motifs serve as docking sites for cytoskeletal proteins, tyrosine kinases, serine/ threonine kinases, GTPase activating proteins and other adaptor proteins that recruit additional enzymes into complex with paxillin. Thus paxillin itself serves as a docking protein to recruit signaling molecules to a speci®c cellular compartment, the focal adhesions, and/ or to recruit speci®c combinations of signaling molecules into a complex to coordinate downstream signaling. The biological function of paxillin coordinated signaling is likely to regulate cell spreading and motility. Oncogene (2001) 20, 6459 ± 6472.
Paxillin was ®rst identi®ed as a 68 ± 70 kDa phosphotyrosine-containing protein in cells transformed by the src oncogene (Glenney Jr and Zokas, 1989) . Further characterization of the protein revealed that paxillin localized to discrete structures in the cell called focal adhesions, which are sites of close cellular contact with the underlying extracellular matrix (Turner et al., 1990) . Tyrosine phosphorylation of paxillin was observed following integrin-dependent cell adhesion to extracellular matrix proteins, thus implicating paxillin in integrin-mediated signaling (Burridge et al., 1992) . These early ®ndings generated a great deal of interest in paxillin providing the impetus for extensive analysis of the protein. These studies have provided us with our current vision of paxillin, a focal adhesion-associated signaling molecule that functions as an adaptor protein to recruit diverse cytoskeleton and signaling proteins into a complex, presumably to coordinate the transmission of downstream signals.
The molecular cloning of paxillin revealed a number of motifs that are now known to function in mediating protein ± protein interactions (see Figure 1 ) (Turner and Miller, 1994; Salgia et al., 1995a) . The N-terminal half of paxillin contains a proline-rich region that could serve as an SH3 domain-binding site. Several tyrosine residues conforming to SH2 domain binding sites were also noted. In addition, the N-terminal domain of paxillin contains ®ve copies of a peptide sequence, called the LD motif, which are now known to function as binding sites for other proteins (see Table 1 ) (Brown et al., 1998a) . The C-terminal half of paxillin is comprised of four LIM domains, which are zinc-binding structures resembling a double zinc ®nger domain. These domains were ®rst identi®ed in three transcription factors, lin-11, isl-1, mec-3. LIM domains can also function to mediate protein-protein interactions (Dawid et al., 1998) . The focal adhesion targeting sequence of paxillin is located in the C-terminal half of the protein. The 3rd LIM domain plays a major role in targeting paxillin to focal adhesions, whereas LIM domain 2 plays a minor role (Brown et al., 1996) . Presumably these LIM domains engage binding partners to direct and/or tether paxillin in focal adhesions, but these binding partners have thus far eluded identi®cation. Since paxillin does not exhibit enzyme activity, but contains an array of docking sites for other proteins, it is believed to function as an adaptor protein that facilitates the assembly of multiprotein complexes to coordinate signaling.
Paxillin: alternative splicing and related proteins
The ®rst paxillin isoform isolated, referred to as paxillin a, is broadly expressed. Two alternatively spliced variants of paxillin, paxillin b and paxillin g, have been described (Mazaki et al., 1997) . Both of these isoforms contain a short exon inserted just downstream of LD motif 4, between lysine residue 277 and phenylalanine residue 278 of paxillin a. Paxillin b contains a 34 amino acid insertion and paxillin g contains a 48 residue insertion that is unrelated in sequence to the paxillin b speci®c exon. The expression pattern of paxillin b and paxillin g is more restricted than the expression of paxillin a (Mazaki et al., 1997) . In fact, paxillin g may be a human speci®c isoform since the murine paxillin gene lacks the exon encoding the g-speci®c isoform sequences (Mazaki et al., 1998) . Interestingly, the insertions appear to alter the ability of these paxillin isoforms to interact with other proteins (Mazaki et al., 1997) . Compared to paxillin a, paxillin b exhibits reduced binding to vinculin in vitro, but equivalent binding to FAK. In contrast, paxillin g is defective for FAK binding in vitro but retains vinculin-binding activity. It is not clear why these isoforms exhibit altered binding to FAK and vinculin since the insertions do not appear to disrupt the LD4 motif, which is a FAK/vinculin binding site (see below). Further, both FAK and vinculin can bind to other LD motifs in the N-terminus of paxillin (see below), which are distant from the isoform speci®c insertions. Perhaps the insertions disrupt interactions with other binding partners that stabilize the association of FAK or vinculin with paxillin. Alternatively, these insertions may alter the conformation of the protein masking recognition of both the LD2 and LD4 motifs by FAK or vinculin.
Paxillin is the founding member of a family of related proteins that now contains three members, paxillin, hic-5 and leupaxin (see Figure 2 ). Hic-5 was originally isolated from a screen for TGF-b and hydrogen peroxide inducible genes (Shibanuma et al., 1994) . Hic-5 is 57% identical to paxillin and contains an organization of N-terminal LD motifs and Cterminal LIM domains similar to paxillin. Hic-5 localizes to focal adhesions and shares a number of binding partners with paxillin including FAK (Hagmann et al., 1998; Thomas et al., 1999a; Ishino et al., 2000a) . The leupaxin cDNA was originally isolated from a macrophage library and its expression in Figure 1 Diagram of paxillin. The ®ve LD motifs in the Nterminal half of paxillin and the four C-terminal LIM domains are diagrammed. The proline-rich sequence and sites of tyrosine phosphorylation within the N-terminal domain of paxillin are indicated. Sites of serine/threonine phosphorylation and the major focal adhesion targeting sequence of paxillin are also shown 
The LD motifs from the human paxillin (Salgia et al., 1995a) , murine hic-5 (Thomas et al., 1999a) , Drosophila paxillin (Dmpax) (Wheeler and Hynes, 2001 ) and leupaxin (Lipsky et al., 1998) . Note that Drosophila paxillin does not contain a conserved LD1 or LD3 and that the leupaxin LD2 motif is not conserved in paxillin. Both hic-5 and leupaxin contain only four LD domains. Highly conserved leucine and aspartic acid residues within the LD motif are highlighted in bold Figure 2 The paxillin family of proteins. A schematic illustration comparing paxillin with hic-5 and leupaxin is shown. The proline-rich region is indicated as a black oval and LD motifs as white ovals. The location of alternatively splice exon insertions within paxillin is indicated. The LD motifs of hic-5 and leupaxin are designated 1, 2, 4 or 5 in this Figure to re¯ect sequence homology between the hic-5 or leupaxin LD motifs and speci®c LD motifs in paxillin. Note that the second LD motif of leupaxin is not highly related to any of the paxillin LD motifs and the Nterminal LD motif of hic-5 (*) is present in the murine hic-5 sequence but not the human hic-5 sequence. The per cent identity between dierent regions of hic-5 or leupaxin and the corresponding regions of paxillin are indicated lymphoid tissue documented (Lipsky et al., 1998) . Leupaxin exhibits 37% identity with paxillin and contains the same domain organization as paxillin with N-terminal LD motifs and four C-terminal LIM domains (Lipsky et al., 1998) . As expected from the sequence conservation, leupaxin can associate with a number of the same proteins that can bind paxillin including the FAK-related protein, CAKb/Pyk2/ CadTK/RAFTK (Lipsky et al., 1998) . It is anticipated that some of the functions of paxillin, hic-5 and leupaxin overlap given the high degree of sequence identity within the LD motifs and LIM domains. However, within the N-terminal domains of these proteins are regions of sequence divergence, suggesting that each protein might also perform unique functions (see Figure 2 ).
The N-terminus of paxillin: LD motif binding partners
Paxillin-associated, actin-binding proteins
Vinculin Vinculin, a focal adhesion-associated protein that functions in linking the actin cytoskeleton to focal adhesions was the ®rst paxillin binding partner to be identi®ed (Turner et al., 1990) . Vinculin binds to the N-terminal domain of paxillin and appears to associate with three dierent sites, LD1, LD2 and LD4 (Brown et al., 1996; Turner et al., 1999) . The binding site on vinculin resides between residues 978 ± 1000 (Wood et al., 1994) . Comparison of the sequence of this region of vinculin (actually residues 951 ± 1000) with several other paxillin binding partners that also associate via the LD motifs has revealed sequence similarity (Tachibana et al., 1995; Nikolopoulos and Turner, 2000; Nikolopoulos and Turner, 2001 ). This sequence has been called the paxillin binding sequence (PBS) and where tested, mutations within the PBS disrupt the association of these proteins with paxillin (see Table 2 ). The PBS in vinculin is in the same region of the protein that may function in promoting the localization of vinculin to focal adhesions (Wood et al., 1994) . Although this observation suggests that paxillin may play a role in targeting vinculin to focal adhesions, vinculin also contains a second focal adhesion targeting sequence in its N-terminus. Vinculin also contains talin-and actin-binding sites and the interaction of vinculin with these proteins is regulated by phosphatidylinositol-bisphosphate (Gilmore and Burridge, 1996) . Vinculin may function to connect the actin cytoskeleton to paxillin.
Actopaxin Actopaxin is a 42-kDa protein that binds LD1 and LD4 of paxillin (Nikolopoulos and Turner, 2000) . Actopaxin has two calponin homology domains, which usually function to bind actin, and actopaxin exhibits F-actin binding activity. There is a PBS in actopaxin and this sequence is part of the paxillindocking site on actopaxin. In cells, actopaxin localizes to focal adhesions and correct localization is dependent upon paxillin binding. Initial experiments using a dominant negative strategy to perturb actopaxin function suggests that this protein functions in spreading and adhesion (Nikolopoulos and Turner, 2000) . Why does paxillin associate with several actinbinding proteins? Two functions can be proposed for these complexes. First, this could simply be an additional mechanism for anchoring the actin cytoskeleton in focal adhesions (see Figure 3) . A second, more intriguing scenario is that actopaxin and vinculin tether paxillin (and associated proteins) to the actin cytoskeleton so that actin-based contractility causes clustering of paxillin and associated proteins (see Figure 3 ). This may be an important mechanism for activation of paxillin associated signaling molecules. In this regard it 
A sequence alignment of the PBS's identi®ed in vinculin (residues 951 ± 1000), FAK (PBSI, residues 919 ± 938 and PBS2, residues 1029 ± 1043) (Tachibana et al., 1995) , ILK (residues 337 ± 396) (Nikolopoulos and Turner, 2001 ) and actopaxin (residues 273 ± 290) (Nicholopoulos and Turner, 2000) . Mutation of the bold residues disrupts binding to paxillin. It may be noteworthy that the two residues implicated in paxillin binding within PBS1 of FAK are not conserved in DFak56, the Drosophila homolog of FAK (Fox et al., 1999; Palmer et al., 1999; Fujimoto et al., 1999b ) is noteworthy that stimuli that promote contractility induce tyrosine phosphorylation of paxillin and the activation of FAK, whereas inhibition of actin polymerization or contractility frequently inhibits signaling events in focal adhesions (Burridge and Chrzanowska-Wodnicka, 1996) .
Paxillin associated enzymes
GTPase activating proteins (GAPs) for the ARF family of GTP-binding proteins Recently, a number of proteins with ARF-GAP activity have been shown to bind to paxillin. PKL (paxillin-kinase linker) is a 95 kDa protein that can bind to the LD4 motif of paxillin and hic-5 . Avian PKL is highly related to murine Git2 and contains an Nterminal ARF-GAP domain. Two PBSs have been identi®ed in PKL, one near the N-terminal ARF-GAP domain and the second near the C-terminus. The binding site for paxillin lies within the C-terminal 309 residues suggesting that the second PBS mediates binding to paxillin. Git1 is another ARF-GAP that is highly related in sequence to PKL . Like PKL, Git1 also associates with paxillin and the Cterminal PBS of Git1 is likely to mediate this interaction (Zhao et al., 2000) . Both PKL and Git1 associate with PIX, a guanine nucleotide exchange factor for Rho family GTP-binding proteins, and paxillin can indirectly associate with PIX via interactions with PKL or Git1 Zhao et al., 2000) . Thus, in addition to their ARF-GAP catalytic function, PKL and Git1 also function as adaptor proteins recruiting an additional enzyme into complex with paxillin. Further, PIX associates with the PAK serine/threonine kinase, and paxillin has been shown to associate indirectly with PAK via PKL and PIX . Git2s is an alternatively spliced isoform of Git2, which is missing the Cterminal sequences of Git2 including the C-terminal PBS. Nevertheless, Git2s also associates with paxillin, albeit less strongly than full length Git2 . The N-terminal region of Git2s, which contains the N-terminal PBS, mediates its interaction with paxillin. In addition, another ARF-GAP called PAG3 (paxillin-binding proteins bearing ARF-GAP motifs) also binds to paxillin, although the details of the interaction have not been fully elucidated (Kondo et al., 2000) . Interestingly, PAG3 was also identi®ed as a CAKb/Pyk2-associated ARF-GAP called PAPa (Andreev et al., 1999) . The adaptor function of PKL/Git1 may be a mechanism to recruit PIX and PAK into complex with paxillin, which may be very important for coordinating the activation and transmission of signals downstream of Rho proteins to regulate the dynamics of the actin cytoskeleton. However, the observation that four dierent ARF-GAP proteins can complex with paxillin, suggests that regulation of ARF proteins is an important aspect of paxillin signaling. The paxillinassociated ARF-GAPs may regulate subcellular localization of paxillin (see below). There is also some evidence that these ARF-GAP proteins can regulate cell motility (Zhao et al., 2000; Kondo et al., 2000; Mazaki et al., 2001) . The mechanisms of regulation of cell motility by paxillin and these ARF-GAPs remain to be elucidated.
Kinases
ILK ILK is a serine/threonine protein kinase that was isolated as a b1 integrin binding partner in a yeast 2-hybrid assay (Dedhar, 2000) . In cells, ILK co-localizes with integrins in focal adhesions. ILK can bind speci®cally to the LD1 motif of paxillin both in vitro and in vivo (Nikolopoulos and Turner, 2001) . Within the C-terminal domain of ILK is a sequence related to the PBS found in vinculin and mutations within the PBS abrogate binding to paxillin in vitro. The Cterminal domain of ILK also contains a binding site for b1 and b3 integrins and interactions with the cytoplasmic domains of these integrin subunits may be important for localization (Dedhar, 2000) . In addition, an interaction between the N-terminal domain of ILK and the LIM domain protein PINCH has also been implicated in targeting ILK to focal adhesions (Dedhar, 2000) . It has now been shown that mutations in the PBS of ILK that disrupt paxillin binding also dramatically impair the ability of ILK to localize to focal adhesions (Nikolopoulos and Turner, 2001 ). Targeting of ILK to focal adhesions is clearly complex and it appears that association with multiple binding partners, one of which is paxillin, may be required for ILK localization to focal adhesions.
PAK3 Although PAK can be indirectly recruited to paxillin via PKL and PIX interactions , there is also evidence that PAK3 can directly associate with paxillin. The PIX binding site on PAK3 resides between residues 184 and 205 . In vitro, the N-terminal proline-rich fragment of PAK3 spanning residues 1 to 62 can bind paxillin . Thus, at least in vitro, PAK3 can bind to paxillin independently of PIX. The binding site for the N-terminus of PAK3 on paxillin has been localized to LD4 . Further, in coexpression experiments PIX and PAK3 can compete with each other for paxillin binding. These results suggest that there may be two mechanisms utilized by paxillin to recruit PAK3 into a signaling complex.
FAK and CAKb/Pyk2/CadTK/RAFTK The focal adhesion kinase, FAK, is another paxillin binding partner (Turner and Miller, 1994; Hildebrand et al., 1995) . The paxillin binding site on FAK is within the C-terminal focal adhesion targeting sequence of FAK . FAK binds to two sequences in paxillin, LD2 and LD4 (Brown et al., 1996) . By comparison of the sequence of the regions of FAK and vinculin that associate with paxillin, a region of homology was de®ned, i.e. the PBS (Tachibana et al., 1995) . While the PBS is a contiguous sequence within vinculin, the sequence is separated into two noncontiguous sequences in FAK, called PBS1 and PBS2. Mutations within PBS1 and PBS2 disrupt paxillin binding and focal adhesion targeting of FAK (Tachibana et al., 1995) . This ®nding suggested that FAK localizes to focal adhesions by binding paxillin. However, additional mutations outside of this region of homology with vinculin also abrogate the paxillin binding activity of FAK . Further, additional mutants of FAK that are defective for binding paxillin still retain the ability to target to focal adhesions (Schaller et al., 1993; Hildebrand et al., 1995; . Thus association with paxillin is dispensable for the correct localization of FAK. However, every mutant of FAK that fails to target to focal adhesions is also defective for paxillin binding Tachibana et al., 1995; Cooley et al., 2000) . The most likely explanation for these paradoxical observations is that interactions with two distinct binding partners can promote focal adhesion targeting of FAK and that interactions with both of these binding partners, one of which is paxillin, must be disrupted to abolish the localization of FAK.
CAKb/Pyk2/CadTK/RAFTK is a FAK-related tyrosine kinase that is highly homologous to FAK within several regions, including the C-terminal focal adhesion targeting sequence. Not surprisingly, CAKb also associates with paxillin (Salgia et al., 1996; Schaller and Sasaki, 1997; Li and Earp, 1997; Hiregowdara et al., 1997) . Although CAKb contains a functional focal adhesion targeting sequence (Schaller and Sasaki, 1997) , CAKb is not strongly localized to focal adhesions in many cell types, but rather is distributed in the cytoplasm (Schaller and Sasaki, 1997; Sieg et al., 1998; Zheng et al., 1998; Litvak et al., 2000) . Under certain conditions CAKb can be stimulated to translocate to focal adhesions and under these conditions the amount of paxillin associated with CAKb is dramatically increased (Litvak et al., 2000) . Although there are several interpretations for this observation, it is consistent with the theory that association with paxillin is important for the relocalization of CAKb to focal adhesions.
The association of paxillin with FAK and CAKb could also play an important role in directing phosphorylation of paxillin by these tyrosine kinases. A paxillin mutant that is unable to bind FAK exhibits reduced steady state levels of phosphotyrosine, reduced tyrosine phosphorylation following cell adhesion to ®bronectin and reduced tyrosine phosphorylation in Src transformed cells (Thomas et al., 1999b) . CAKb can induce tyrosine phosphorylation of hic-5 and the induction of tyrosine phosphorylation depends upon the binding of hic-5 to the C-terminus of CAKb (Ishino et al., 2000b) . These data support the contention that association of paxillin with FAK and CAKb is a mechanism to promote tyrosine phosphorylation of paxillin.
The translation product of a viral oncogene E6 The E6 oncoproteins from human papillomavirus 16 and bovine papillomavirus have several cellular binding partners whose function may be coopted in the process of oncogenic transformation. Using dierent strategies, two groups have identi®ed paxillin as a binding partner for E6 Vande Pol et al., 1998) . E6 interacts with several LD motifs of paxillin in vitro, although the most important in vivo binding site appears to be LD1 Vande Pol et al., 1998) . While it is clear that paxillin is not the sole E6 target within the cells, analysis of E6 mutants has provided a correlation between paxillin binding and transformation Das et al., 2000) . Thus paxillin may be one of several cellular proteins whose function is altered upon transformation by the papillomaviruses. The mechanism of action of the oncoprotein is not yet clear but likely involves disruption of normal paxillin-containing protein complexes. In vitro, recombinant E6 protein can associate with recombinant paxillin and block subsequent interactions between paxillin and FAK or vinculin . It is also interesting to observe that expression of E6 disrupts actin stress ®bers. Since the actin cytoskeleton is potentially linked to paxillin via actopaxin and vinculin, this phenotype may be due to E6 binding to paxillin and disrupting interactions with actopaxin and vinculin Nikolopoulos and Turner, 2000) .
LD motif mediated interactions: specificity, affinity and regulation
Clearly the LD motifs within the N-terminal domain of paxillin play very important roles in the assembly of actin-binding proteins and signaling proteins into complexes (see Figures 3 and 4) . The ®nding that many dierent proteins associate with LD motifs of paxillin raises some very important questions about these interactions. How do these LD motifs interact with their binding partners? What dictates speci®city of the interactions? Why do some proteins bind to multiple LD motifs? How do dierent paxillin binding partners compete for binding? How are these interactions regulated?
Within every LD motif the core consensus sequence is conserved. However, comparison of the sequence of individual LD motifs between species or between family members reveals that sequences in addition to the core consensus motif are conserved. For example, comparison of the LD4 motif of human paxillin with the LD4 motif of frog paxillin and the LD4 motif of hic-5 reveals a high degree of sequence conservation extending beyond the core consensus. These sequences are likely to provide the speci®city for interaction with individual paxillinbinding partners. While this theory remains to be rigorously tested, there is one reported point mutation within an LD motif that disrupts vinculin binding but does not aect FAK binding (Brown et al., 1996) . Comparison of the sequences of the LD motifs might provide additional clues to the speci®city of interaction. For example, FAK binds to LD2 and LD4 (Brown et al., 1996; Thomas et al., 1999b) . Comparison of the sequences of LD2 and LD4 motifs among the paxillin family members and between species reveals three additional highly conserved residues upstream of the core LD motif consensus (see Table 3 ). These residues may provide the speci®city in the LD2/LD4 interaction with FAK.
In addition to the problem of how binding partners distinguish dierent LD motifs, there can be multiple proteins that are capable of binding to a single LD motif. In some instances, e.g. PIX and PAK3 binding to LD4 and E6, FAK and vinculin binding to recombinant paxillin, these proteins were shown to compete for binding to the LD motif Hashimoto et al., 2001) . Clearly the nature of the signaling complex will be dierent depending upon which binding partner successfully competes to bind paxillin. The anity of each of the paxillin binding partners for the LD motif might be an important factor in determining the nature of the assembled complex. The anity of interaction between FAK and the paxillin LD2 motif and LD4 motif has been estimated by surface plasmon resonance (Thomas et al., 1999b) . The dissociation constants for the interaction of the C-terminal domain of FAK with the LD2 and LD4 motifs are 3 ± 4 mM. The dissociation constant for the interaction of the C-terminal domain of FAK with a fragment of paxillin containing both LD2 and LD4 is less than 1 mM. Although the mechanism hasn't been established, this result demonstrates that the presence of two FAK binding sites on paxillin dramatically increases the anity for FAK. This may explain why individual paxillin binding partners have evolved to associate with more than one LD motif. Future studies exploring the anity of paxillin for its binding partners, elucidating the components found in individual paxillin containing complexes and understanding how these interactions are regulated are essential for determining how these complexes function.
Association of paxillin with integrins
Paxillin can bind in vitro to synthetic peptides mimicking the cytoplasmic domain of the b1 and b3 integrins . Further under some circumstances paxillin can coimmunoprecipitate with integrins (Chen et al., 2000) . Beyond these initial observations, little is known about the interaction between paxillin and the cytoplasmic tails of the b integrin subunits. Paxillin also binds to the cytoplas- Figure 4 LD motifs recruit signaling molecules. A diagram denoting the assembly of a diverse set of signaling proteins with the LD motifs of paxillin is shown. These multi-protein complexes could regulate serine/threonine and tyrosine phosphorylation of downstream proteins and the active state of two classes of GTPbinding proteins, the ARF family and Rho family proteins, e.g. Rac Table 3 Human paxillin LD2:
Alignment of the sequences of the LD2 and LD4 motifs of human paxillin (Salgia et al., 1995a) , X. laevis paxillin (Amph.) (Genbank accession number AF317890), Drosophila paxillin (Fly) (Wheeler and Hynes, 2001), murine hic-5 ( Thomas et al., 1999a) and leupaxin (Lipsky et al., 1998) . These LD motifs are believed to mediate binding to FAK. For comparison, two LD motifs that do not bind FAK are shown, human paxillin LD motifs 3 and 5. Conserved residues are highlighted in bold. Note that the FAK binding sequences contained conserved sequences to the Nterminus of the highly conserved sequences within the core LD motif mic domain of the a4 integrin and the interaction appears signi®cantly stronger than the reported interaction between paxillin and b integrin subunits (Liu et al., 1999) . The interaction of paxillin with a4 has been demonstrated in vitro using synthetic peptides and in vivo by coimmunoprecipitation. Two a4 residues that are critical for paxillin binding have been identi®ed (Liu and Ginsberg, 2000) . The site of interaction of paxillin has not been de®ned, but the a4 cytoplasmic domain can bind both hic-5 and leupaxin in addition to paxillin. Thus the site of interaction is likely in sequences conserved between the three, most likely the LD motifs or LIM domains. The function of paxillin binding to a4 is apparently to regulate cell spreading and motility (Liu et al., 1999) .
Phosphorylation of paxillin

Multiple stimuli induce tyrosine phosphorylation of paxillin
The ®rst stimulus shown to induce tyrosine phosphorylation of paxillin was integrin-dependent cell adhesion to extracellular matrix proteins. Stimulation with growth factors, neuropeptides, ligands for Gprotein coupled receptors, antigen and physical stress have all been reported to stimulate tyrosine phosphorylation of paxillin. Thus a large number of very diverse stimuli converge to stimulate paxillin phosphorylation. A selected list of stimuli shown to induce tyrosine phosphorylation of paxillin is presented in Table 4 . 
Phosphorylation of paxillin by tyrosine kinases
Although a large number of stimuli induce tyrosine phosphorylation of paxillin, only a few tyrosine kinases have been implicated in regulating tyrosine phosphorylation of paxillin. The focal adhesion kinase, FAK, and the FAK-related protein, CAKb/Pyk2/CadTK/ RAFTK, are major players in controlling tyrosine phosphorylation of paxillin. These proteins can colocalize with paxillin in vivo, physically associate with paxillin, and tyrosine phosphorylation/activation of these tyrosine kinases is frequently correlated with tyrosine phosphorylation of paxillin (Schlaepfer et al., 1999; Avraham et al., 2000) . Overexpression of FAK and CAKb promotes tyrosine phosphorylation of paxillin in vivo Frisch et al., 1996; Schaller and Sasaki, 1997) . Although fak 7/7 ®broblasts exhibit normal tyrosine phosphorylation of paxillin, this may be the result of compensatory expression of CAKb in these cells (Ilic et al., 1995; Sieg et al., 1998; Owen et al., 1999) . Inhibition of FAK signaling using a dominant negative strategy inhibits tyrosine phosphorylation of paxillin in ®broblasts (Richardson and Parsons, 1996) . These lines of investigation provide compelling evidence that FAK/ CAKb regulate tyrosine phosphorylation of paxillin.
Members of the Src family of tyrosine kinases are also candidate kinases for the phosphorylation of paxillin. Paxillin was originally identi®ed as a tyrosine phosphorylated protein in src-transformed ®broblasts (Glenney Jr and Zokas, 1989) . Genetic evidence has also implicated Src family kinases in the regulation of tyrosine phosphorylation of paxillin under physiological conditions. Fibroblasts derived from csk 7/7 mice (Csk, the C-terminal Src kinase, is the major regulatory kinase of Src that functions to negatively regulate the catalytic activity of Src family kinases) exhibit enhanced activity of Src family kinases and increased tyrosine phosphorylation of their substrates including paxillin (Thomas et al., 1995) . Further genetic evidence from the analysis of cells de®cient for expression of Src family kinases also supports a role for these kinases in regulating tyrosine phosphorylation of paxillin. Fibroblasts lacking Src, Fyn and Yes exhibit dramatic reductions in adhesion dependent tyrosine phosphorylation of paxillin (Klinghoer et al., 1999) . Peritoneal macrophages from hck 7/7 /fgr 7/7 mice also exhibit defective tyrosine phosphorylation of paxillin upon adhesion to extracellular matrix proteins suggesting that these Src family kinases function in tyrosine phosphorylation of paxillin in macrophages (Suen et al., 1999) . These results strongly implicate the Src family kinases in regulating paxillin phosphorylation.
The mechanism by which FAK/CAKb and Src kinases induce tyrosine phosphorylation of paxillin may be complex. Activation of FAK/CAKb results in the recruitment of Src kinases into complex with FAK and CAKb. One substrate for the Src kinases is FAK/ CAKb and one consequence of Src-dependent phosphorylation is an elevation in the catalytic activity of FAK/CAKb. Thus Src kinases could directly phosphorylate paxillin or indirectly promote paxillin phosphorylation by activation of FAK/CAKb. In turn, FAK/CAKb could directly phosphorylate paxillin or indirectly promote paxillin phosphorylation by recruiting Src kinases into complex, which then phosphorylate paxillin.
Tyrosine phosphorylation of paxillin is elevated in Bcr-Abl transformed 32D cells, suggesting that this oncogenic fusion protein might target paxillin for tyrosine phosphorylation (Salgia et al., 1995a) . In normal ®broblasts, c-Abl may also contribute to tyrosine phosphorylation of paxillin. Upon adhesion, c-Abl transiently translocates from the nucleus to focal adhesions and associates with paxillin (Lewis and Schwartz, 1998) . Further, c-Abl can phosphorylate paxillin in vitro (Lewis and Schwartz, 1998) . Thus cAbl potentially contributes to tyrosine phosphorylation of paxillin in response to cell adhesion.
Csk has also been proposed to phosphorylate paxillin since overexpression of Csk can result in enhanced paxillin phosphorylation (Sabe et al., 1994; Bergman et al., 1995; Takayama et al., 1999) . However, the physiological signi®cance of Csk-mediated tyrosine phosphorylation of paxillin is not clear.
Dephosphorylation of paxillin by tyrosine phosphatases
The regulation of dephosphorylation by tyrosine phosphatases may also be a very important mechanism of controlling paxillin signaling. Several PTPs have recently been implicated in regulating paxillin phosphorylation. PTP-PEST is a 125 kDa protein with an N-terminal catalytic domain and a long C-terminal domain containing proline-rich sequences and PEST sequences (Yang et al., 1993; Charest et al., 1995) . Paxillin and hic-5 bind to one of the proline-rich regions of PTP-PEST (Shen et al., 1998; Cote et al., 1999; Nishiya et al., 1999; Shen et al., 2000) . The PTP-PEST binding site on paxillin and hic-5 resides in the two C-terminal LIM domains Nishiya et al., 1999; Shen et al., 2000) . Overexpression of PTP-PEST results in dephosphorylation of paxillin and the association of paxillin with PTP-PEST via the proline-rich binding site is necessary for dephosphorylation (Shen et al., 2000) . Thus the C-terminal domain of PTP-PEST functions as a docking site targeting paxillin for dephosphorylation. Further, PTP-PEST 7/7 ®broblasts exhibit enhanced tyrosine phosphorylation of paxillin (Angers-Loustau et al., 1999) . It is noteworthy that PTP-PEST binds to the region of paxillin that functions in focal adhesion targeting. PTP-PEST is a cytoplasmic PTP that does not localize to focal adhesions (Charest et al., 1995) . Thus, PTP-PEST may only associate with the population of paxillin that is not found in focal adhesions. This might be a mechanism to ensure dephosphorylation of paxillin as it exits from focal adhesions and maintain dephosphorylation of cytoplasmic pools of paxillin. Alternatively PTP-PEST might target non-focal adhesion-associated pools of paxillin that may function in other signaling pathways.
PTPF is also a candidate PTP for paxillin. Overexpression of PTPF in the BAC1.2F5 macrophage cell line reduces tyrosine phosphorylation of paxillin whereas overexpression of a catalytically inactive mutant of PTPF, which may act as a dominant negative mutant, enhances tyrosine phosphorylation of paxillin (Pixley et al., 2001) . In addition, a substrate trapping mutant of PTPF can weakly associate with paxillin, which is usually indicative of an enzyme/ substrate relationship (Pixley et al., 2001) . Thus PTPF may also target paxillin for dephosphorylation.
Consequences of tyrosine phosphorylation of paxillin
Four sites of tyrosine phosphorylation of paxillin have been identi®ed and a ®fth potential site of phosphorylation suggested, all of which reside in the N-terminal domain of paxillin (see Figure 1) . The major sites of tyrosine phosphorylation are tyrosines 31 and 118, whereas tyrosines 40 and 88 are other minor sites of phosphorylation Bellis et al., 1995; Nakamura et al., 2000) . Tyrosine 181 was also proposed as a site of phosphorylation, but has not de®nitely shown to become phosphorylated (Salgia et al., 1995b; Nakamura et al., 2000) . The only known function of tyrosine phosphorylation of paxillin is to create binding sites for SH2 domain containing signaling proteins. Tyrosine residues 31, 118 and 181 are embedded in high anity binding sites for the SH2 domain of the Crk adaptor protein and phosphorylation of these sites can result in the recruitment of Crk and CrkL into complex with paxillin (Birge et al., 1993; Salgia et al., 1995b) . Crk and CrkL associate via their SH3 domains with other signaling molecules, e.g. the C3G guanine nucleotide exchange factor and Dock 180 (Feller et al., 1998) . Therefore Crk and CrkL function in paxillin signaling to recruit additional signaling molecules into complex with paxillin. Csk and Chk, a Csk-related kinase, can also bind to paxillin via its SH2 domain (Sabe et al., 1994; Bergman et al., 1995; Grgurevich et al., 1999 ) (see Figure 5) .
The SH2 domain of Src can also associate with paxillin in vitro . The Src family kinase Lck can associate with paxillin in vivo in T cells (Ostergaard et al., 1998) . This interaction is direct and is mediated by the SH2 domain of Lck. Although the binding site on paxillin has not been ®rmly established, one of the minor sites of tyrosine phosphorylation, tyrosine 40, is within a sequence resembling a high anity Src SH2 domain binding site . It is also of interest that this tyrosine residue is very close to a proline rich sequence in paxillin ( 46 PPPVPPPP 53 ) that has been shown to bind the SH3 domain of Src in vitro (Weng et al., 1993) . One possibility is that both the SH2 and SH3 domains of Lck may engage paxillin in vivo.
Whereas the LD motifs and LIM domains are highly conserved between paxillin, hic-5 and leupaxin, other sequences in the N-terminal domains of these proteins, including the sites of tyrosine phosphorylation in paxillin, are not conserved. Thus functions speci®c to each protein might be mediated by these unique sequences. Although hic-5 does not contain the Crkbinding sites in its N-terminus, tyrosine 60 is a site of phosphorylation and serves as a binding site for Csk (Ishino et al., 2000b) . Recruitment of Csk could lead to further tyrosine phosphorylation of paxillin or to phosphorylation of Src family kinases to inhibit their catalytic activity.
Serine/threonine phosphorylation of paxillin
Although tyrosine phosphorylation of paxillin has been extensively examined, serine phosphorylation is a far more prevalent posttranslational modi®cation. Paxillin becomes increasingly phosphorylated on serine when ®broblasts attach to ®bronectin or when macrophages adhere to vitronectin (De Nichilo and Yamada, 1996; Bellis et al., 1997) . In addition to adhesion-dependent serine phosphorylation, paxillin also becomes phosphorylated on serine/threonine residues during mitosis and upon stimulation of MCF-7 cells with heregulin (Yamakita et al., 1999; Vadlamudi et al., 1999) .
Several serine/threonine kinases have been suggested to phosphorylate paxillin. The phosphorylation of paxillin in adhering macrophages might be mediated by PKC since inhibitors of PKC block serine phosphorylation of paxillin upon adhesion (De Nichilo and Yamada, 1996) . However, in some cell types activation of PKC can also lead to Erk activation. PMA stimulation of EL4 cells induces a mobility shift in paxillin that is likely due to serine/threonine phosphorylation and this shift can be impaired with MEK inhibitors (Ku and Meier, 2000) . Further paxillin can be phosphorylated in vitro with Erk (Ku and Meier, 2000) . In MCF-7 cells, heregulin induces the activation of p38 and this serine/threonine kinase may be responsible for phosphorylation of paxillin on serine (Vadlamudi et al., 1999) . PAK3, which associates directly and indirectly with paxillin can also phosphorylate paxillin on serine residues in vitro .
In addition to these known kinases, serine/threonine kinase activities can associate with and target three dierent fragments of paxillin for phosphorylation in vitro. A fragment of the N-terminus of paxillin (residues 168 ± 191) can interact with a serine/threonine kinase that can phosphorylate two serine residues on paxillin, residues 188 and 190 (Bellis et al., 1997) . Phosphopeptide mapping suggests that these sites might become phosphorylated upon adhesion of ®broblasts to ®bronectin (Bellis et al., 1997) . LIM domain 2 can bind a kinase that can phosphorylate paxillin on threonine 403 in vitro (Brown et al., 1998b) . LIM domain 3 can bind a kinase that appears to phosphorylate serine residues 457 and 481 in vitro (Brown et al., 1998b) . It has not been established under what conditions the sites of serine/threonine phosphorylation within the LIM domains of paxillin are phosphorylated in vivo.
Three outstanding issues remain in the analysis of serine/threonine phosphorylation of paxillin. Several phosphorylation sites have been identi®ed, but additional studies are required to determine if additional sites of phosphorylation exist. Although a number of candidate kinases for paxillin phosphorylation have been identi®ed, further studies are required to de®ne which kinases control paxillin phosphorylation in response to dierent stimuli. Finally, it is not yet clear what the consequences of serine/threonine phosphorylation of paxillin may be. There is some evidence that serine phosphorylation within LIM domain 3 might function in regulating localization of paxillin (Brown et al., 1998b) . Further, overexpression of paxillin mutants that cannot be phosphorylated on LIM domain phosphorylation sites slightly retards adhesion to ®bronectin, suggesting that paxillin phosphorylation might regulate cell adhesion (Brown et al., 1998b) . While these results may provide the ®rst clues that phosphorylation of these sites regulate localization and adhesion, additional studies are required to fully elucidate the function of phosphorylation of paxillin on serine/threonine residues.
How does paxillin localize to focal adhesions?
The major focal adhesion targeting sequence of paxillin is within LIM domains 2 and 3 (Brown et al., 1996) . These LIM domains presumably function in mediating protein ± protein interactions to target and or tether paxillin in focal adhesions, although the binding partner remains elusive. Although LIM domain binding partners for paxillin and hic-5 have been described, none of these binding partners are found in focal adhesions. As described above, the N-terminal half of paxillin contains binding sites for two focal adhesion-associated proteins, FAK and vinculin, but association with these proteins is not the major mechanism of focal adhesion targeting since they bind outside of the major targeting sequence of paxillin. However, interactions with these proteins, most likely vinculin, may play a minor role in localization of paxillin to focal adhesions, since the N-terminus of paxillin, lacking the LIM domains, weakly targets to focal adhesions (Thomas et al., 1999a) .
One surprising ®nding related to focal adhesion targeting of paxillin came from the analysis of streptolysin-O permeabilized Swiss 3T3 cells. Treatment of permeabilized cells with GTP-g-S promoted the translocation of paxillin from a perinuclear location to structures resembling focal adhesions (Norman et al., 1998) . This eect was rho-independent, since activated rho did not promote the same robust change in the location of paxillin and the GTP-g-S dependent translocation of paxillin was unaected by C3 toxin. Introduction of ARF1 into permeabilized Swiss 3T3 cells or microinjection of ARF1 into intact cells induced the translocation of paxillin to focal adhesion like structures suggesting that ARF1 could control targeting of paxillin to focal adhesions (Norman et al., 1998) . The ARF family of GTP-binding proteins, including ARF1, generally function in membrane/vesicle tracking, although ARF6 may play a role in regulating the actin cytoskeleton (Chavrier and Goud, 1999; Donaldson and Jackson, 2000) . A role for ARF proteins in regulating localization of paxillin to focal adhesions is further supported by studies where ARF-GAP proteins are overexpressed. Overexpression of PAG3, Git2s, Git1 or ASAP1 impair the localization of paxillin to focal adhesions (Zhao et al., 2000; Kondo et al., 2000; Randazzo et al., 2000; Mazaki et al., 2001) . Although three of these ARFGAPs are paxillin associated, and the fourth is found in focal adhesions, it is not clear whether overexpression of these proteins is mimicking the function of the endogenous protein or indiscriminately inhibiting ARF function. At present, the mechanism by which ARF proteins may regulate the translocation of paxillin to focal adhesions is completely speculative. It is intriguing that ARF-GAPs associate with paxillin and could further function in regulating localization of paxillin. It is also interesting to note that PKL and Git1 can localize in focal adhesions Zhao et al., 2000) , whereas Git2s and PAG3 do not (Kondo et al., 2000; Mazaki et al., 2001) . Perhaps association with dierent ARF-GAPs serves to regulate paxillin localization. Binding to Git2s or PAG3 in a non-focal adhesion compartment might inhibit ARFdependent translocation to focal adhesions, maintaining a cytoplasmic population of paxillin.
Does paxillin have a nuclear function?
LIM domains were originally discovered as a motif that was shared by three transcription factors, lin 11, isl-1 and mec-3. Given that these domains are double zinc ®ngers and that zinc ®ngers are important elements in DNA binding proteins like steroid receptors, the possibility that some of the LIM domain containing, focal adhesion-associated proteins might also perform a nuclear function was an attractive hypothesis. In fact, zyxin, another focal adhesionassociated LIM protein, was proposed to shuttle between focal adhesions and the nucleus (Nix and Beckerle, 1997) . Several lines of evidence suggest that hic-5, and perhaps paxillin as well, might have a nuclear function. First, a small fraction of hic-5 and paxillin have been reported to localize to the nucleus and even associate with the nuclear matrix, and this localization was apparently mediated via the Cterminal, LIM domain-containing half of the protein (Thomas et al., 1999a; Yang et al., 2000) . Second, the LIM domains of hic-5 have been reported to bind DNA, although no consensus binding motif for hic-5 has been de®ned (Nishiya et al., 1998) . Third, two dierent two hybrid screens, one using the androgen receptor and the other using the glucocorticoid receptor as bait, have identi®ed hic-5 as a steroid receptor binding protein. Importantly, coexpression of hic-5 with steroid receptors enhances expression of reporter genes in vivo, suggesting that hic-5 can potentiate the activation of gene expression by these transcription factors (Fujimoto et al., 1999a; Yang et al., 2000) . While the hypothesis that hic-5 functions in both the focal adhesions and the nucleus is tantalizing, the importance of hic-5 in signaling to the nucleus is not ®rmly established and a similar role for paxillin is presently only speculative. Nevertheless, these ®ndings seem suciently encouraging that further investigation is warranted.
Biological functions of paxilllin
Paxillin plays a critical role in embryonic development since paxillin 7/7 mice exhibit embryonic lethality by day 9.5 (S Thomas, personal communication). Analysis of paxillin 7/7 ®broblasts reveals defects in cell spreading and in cell motility (S Thomas, personal communication) . Additional studies using other approaches to address the role of paxillin in the cell have produced similar conclusions, that paxillin controls spreading and motility. Expression of a dominant negative mutant of FAK impairs endogenous FAK signaling and delays cell spreading (Richardson and Parsons, 1996) . The eects of this dominant negative mutant can be reversed by overexpression of FAK or Src (Richardson et al., 1997) . There is a good correlation in this series of experiments between reduced tyrosine phosphorylation of paxillin and delayed spreading.
To address the role of tyrosine phosphorylation of paxillin in controlling cell motility, two dierent groups have utilized tyrosine to phenylalanine substitution mutants of paxillin as dominant negative mutants. Expression of a paxillin mutant with phenylalanine substitutions for both tyrosine 31 and 118 in the NBT-II rat bladder carcinoma cell line impaired random motility on collagen by approximately 50% (Petit et al., 2000) . In NBT-II cells, adhesion to collagen promotes the association of Crk with paxillin and overexpression of Crk enhances random motility in NBT-II cells. Further, overexpression of Crk rescues the motility defect in NBT-II cells stably expressing the tyrosine to phenylalanine mutants of paxillin (Petit et al., 2000) . These results suggest that tyrosine phosphorylation of paxillin promotes cell motility by recruiting Crk to sites of paxillin tyrosine phosphorylation. In contrast to these ®ndings, overexpression of wild type paxillin in Cos7 cells or NMuMG cells impaired haptotaxis toward collagen . Further, overexpression of wild type paxillin inhibited the ability of LPA stimulated MM-1 rat hepatoma tumor cells to invade a monolayer of primary mesothelial cells . A paxillin mutant with substitutions for the four sites of tyrosine phosphorylation on paxillin had no eect or even enhanced motility/invasion in these assays . These results suggest that tyrosine phosphorylation of paxillin inhibits cell motility. It is perhaps noteworthy that Crk and CrkI, were shown to associate with p130 cas in the NMuMG cells but not with paxillin. It is dicult to reconcile these two disparate ®ndings. Dierences in cell type or the experimental design to measure motility in the two studies may be the reason for the opposing results. Alternatively, tyrosine phosphorylation of paxillin might have opposing roles in random motility and haptotactic motility. Further investigation will be required to resolve this issue.
Paxillin has also been implicated in the control of cell spreading and motility by the a4 integrin subunit. The a4 integrin functions to inhibit cell spreading and promote motility when expressed exogenously in cells (Liu et al., 1999) . Paxillin plays an essential role in the inhibition of cell spreading by a4 since a a4 mutant that is defective for paxillin binding fails to block spreading. Further, the a4 integrin does not block the spreading of paxillin 7/7 ®broblasts, but can block the spreading of paxillin 7/7 ®broblasts that have been engineered to re-express paxillin.
Concluding remarks
Since the original discovery of paxillin as a tyrosine phosphorylated Src substrate, a number of the details of the function of paxillin have been elucidated. It is now well established that paxillin is a focal adhesion associated adaptor protein that recruits signaling molecules into a complex. Some paxillin-binding partners associate via LD motif interactions, whereas the interactions of others are regulated by phosphotyrosine-dependent interactions. The functions of paxillin appear to include the regulation of cell spreading and cell motility, and these functions are presumably elicited by coordinating signaling events by paxillin associated proteins. Future challenges in the area of paxillin signaling are to de®ne the molecular pathways by which individual paxillin binding partners can aect spreading and or motility, and to determine how the signals from multiple proteins associated with paxillin are integrated to produce a coordinated biological response.
